Honokiol protects against diabetic retinal microvascular injury via sirtuin 3-mediated mitochondrial fusion
2024

Honokiol Protects Against Diabetic Retinal Injury

Sample size: 3 publication 10 minutes Evidence: moderate

Author Information

Author(s): Shi Jiemei, Liu Min, Zhao Jiajie, Tan Ye, Jiang Chunhui

Primary Institution: Eye and ENT Hospital, Fudan University, Shanghai, China

Hypothesis

Can honokiol ameliorate vascular injury in diabetic retinopathy and what are its mechanisms of action?

Conclusion

Honokiol inhibits vascular injury in diabetic retinopathy, likely through SIRT3-mediated mitochondrial fusion.

Supporting Evidence

  • Honkoli reversed retinal vascular leakage in diabetic mice.
  • Honkoli improved retinal capillary endothelial cell viability and decreased apoptosis.
  • Honkoli reduced oxidative stress and mitochondrial fragmentation in retinal cells.

Takeaway

Honokiol is a natural compound that helps protect the eyes from damage caused by diabetes by improving the health of tiny blood vessels.

Methodology

The study used an in vivo type 2 diabetic mouse model and in vitro retinal microvascular endothelial cells treated with high glucose to assess the effects of honokiol.

Limitations

The study had a limited number of animal subjects and did not comprehensively evaluate the effects of honokiol in diabetic mice.

Participant Demographics

Male BKS wild-type and BKS-db mice, 8 weeks old.

Statistical Information

P-Value

p<0.001

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.3389/fphar.2024.1485831

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication